BACKGROUND: Valvar heart disease is an important public health problem, more common in developing countries, especially in younger. OBJECTIVE: To evaluate the epidemiological features of patients and its influence on the prosthesis type choice used on patients who underwent valve surgery. METHODS: Cross-sectional. Data such as age, sex, provenance, surgery procedure and prosthesis type were retrospectively analyzed. We reviewed 366 charts of all patients submitted to heart valve surgery during three years in a public health cardiovascular treatment center. RESULTS: 52% of patients were female. The age range was from 5 to 82, the median was 41 years old. In regards 37.7% of patients came from Salvador (Bahia, Brazil) and 62.3% from countryside. Valve replacement was performed in 73% of patients, whereas 7.38% underwent valvuloplasty and 18.3% underwent valve repair and replacement. Regarding type of prosthesis, 70.0% received bioprosthesis and 30.0% received metal prosthesis. On note bioprosthesis were more used in younger (P<0,001). CONCLUSION: Biological prostheses were used predominantly in younger. This might be possible due to a low social-economic status, avoiding metal valve implantation and the consequent anticoagulation therapy.
BACKGROUND: Valvar heart disease is an important public health problem, more common in developing countries, especially in younger. OBJECTIVE: To evaluate the epidemiological features of patients and its influence on the prosthesis type choice used on patients who underwent valve surgery. METHODS: Cross-sectional. Data such as age, sex, provenance, surgery procedure and prosthesis type were retrospectively analyzed. We reviewed 366 charts of all patients submitted to heart valve surgery during three years in a public health cardiovascular treatment center. RESULTS: 52% of patients were female. The age range was from 5 to 82, the median was 41 years old. In regards 37.7% of patients came from Salvador (Bahia, Brazil) and 62.3% from countryside. Valve replacement was performed in 73% of patients, whereas 7.38% underwent valvuloplasty and 18.3% underwent valve repair and replacement. Regarding type of prosthesis, 70.0% received bioprosthesis and 30.0% received metal prosthesis. On note bioprosthesis were more used in younger (P<0,001). CONCLUSION: Biological prostheses were used predominantly in younger. This might be possible due to a low social-economic status, avoiding metal valve implantation and the consequent anticoagulation therapy.
Authors: André Mauricio S Fernandes; Felipe da Silva Pereira; Larissa Santana Bitencourt; Agnaldo Viana Pereira Neto; Gabriel Barreto Bastos; André Rodrigues Durães; Roque Aras; Igor Nogueira Lessa Journal: Rev Bras Cir Cardiovasc Date: 2014 Oct-Dec
Authors: Larissa S Freitas; Núbia Caroline C Almeida; Maria Alice Freitas Queiroz; Marcelo M Zaninotto; Hellen T Fuzii; Alfredo Ribeiro-Silva; Antonio Cr Vallinoto; Marluísa Og Ishak; Juarez As Quaresma; Ricardo Ishak Journal: Infect Drug Resist Date: 2017-04-10 Impact factor: 4.003
Authors: Francisco Artur Forte Oliveira; Clarissa Pessoa Fernandes Forte; Paulo Goberlânio de Barros Silva; Camile B Lopes; Raquel Carvalho Montenegro; Ândrea Kely Campos Ribeiro Dos Santos; Carlos Roberto Martins Rodrigues Sobrinho; Mário Rogério Lima Mota; Fabrício Bitu Sousa; Ana Paula Negreiros Nunes Alves Journal: Medicine (Baltimore) Date: 2015-11 Impact factor: 1.817